Olaparib improved invasive disease-free survival, distant disease-free survival, and overall survival in high-risk ...

Katie and Lyndsay Cooper regularly monitored their breasts since discovering they had the BRCA1 mutation. Eventually, the ...

The global cancer diagnostics market is poised for significant growth, with projections indicating an increase from USD 60.4 billion in 2024 to a robust USD 136.7 billion by 2034. This market is ...

The astrophysicist is using preimplantation genetic testing (PGT) to eliminate her future children’s risk of inheriting the ...

Mathew Knowles, father of Beyoncé and Solange, shares his journey as both a music legend and a breast cancer survivor.

This month's cover highlights the article A novel bacterial effector protein mediates ER-LD membrane contacts to regulate ...

The Australian government announces Olaparib now available on the PBS for HER2-negative metastatic breast cancer patients with mutated BRCA1 or BRCA2 gene.

Australians with prostate and breast cancer now have affordable access to affordable new and expanded medicines under the ...

Large research symposium highlights liquid biopsies, new drug combos, shifts in surgical practice and, yes, patient voices.

We are deep into the festive season — a time for family, friends, and, the occasional indulgence. But also take the time to think about a gift you can give ...

A phase 1 trial evaluating FSHR-targeting CAR T cells for patients with ovarian cancer has dosed the first patient in its ...